- Home
- LICN vs KZR Comparison
LICN vs KZR Comparison
Compare LICN & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- KZR
- Stock Information
- Founded
- LICN 2004
- KZR 2015
- Country
- LICN China
- KZR United States
- Employees
- LICN N/A
- KZR N/A
- Industry
- LICN
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- LICN
- KZR Health Care
- Exchange
- LICN Nasdaq
- KZR Nasdaq
- Market Cap
- LICN 3.8M
- KZR 29.7M
- IPO Year
- LICN 2023
- KZR 2018
- Fundamental
- Price
- LICN $4.66
- KZR $3.74
- Analyst Decision
- LICN
- KZR Hold
- Analyst Count
- LICN 0
- KZR 2
- Target Price
- LICN N/A
- KZR $9.00
- AVG Volume (30 Days)
- LICN 84.7K
- KZR 30.5K
- Earning Date
- LICN 01-01-0001
- KZR 11-11-2025
- Dividend Yield
- LICN N/A
- KZR N/A
- EPS Growth
- LICN N/A
- KZR N/A
- EPS
- LICN N/A
- KZR N/A
- Revenue
- LICN $41,477,000.00
- KZR N/A
- Revenue This Year
- LICN N/A
- KZR N/A
- Revenue Next Year
- LICN N/A
- KZR N/A
- P/E Ratio
- LICN N/A
- KZR N/A
- Revenue Growth
- LICN 4.32
- KZR N/A
- 52 Week Low
- LICN $2.60
- KZR $3.62
- 52 Week High
- LICN $462.00
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- LICN 49.94
- KZR 35.98
- Support Level
- LICN $4.59
- KZR $3.76
- Resistance Level
- LICN $5.30
- KZR $4.05
- Average True Range (ATR)
- LICN 0.48
- KZR 0.13
- MACD
- LICN -0.01
- KZR -0.01
- Stochastic Oscillator
- LICN 31.25
- KZR 6.82
About LICN Lichen China Limited
Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.